Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice

The therapeutic sc"enario of metastatic renal cell cancer (mRCC) has noticeably increased, ranging from the most studied molecular target therapies to those most recently introduced, up to immune checkpoint inhibitors (ICIs). The most recent clinical trials with an ICI-based combination of mole...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Oncol
Prif Awduron: Roberto, Michela, Botticelli, Andrea, Panebianco, Martina, Aschelter, Anna Maria, Gelibter, Alain, Ciccarese, Chiara, Minelli, Mauro, Nuti, Marianna, Santini, Daniele, Laghi, Andrea, Tomao, Silverio, Marchetti, Paolo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2021
Pynciau:
Oncology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100507/
https://ncbi.nlm.nih.gov/pubmed/33968762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.657639
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg